Who owns ImmunoGen?

Key details on ImmunoGen (Ticker: IMGN)

Who owns ImmunoGen?

Is IMGN a good stock to own? Find out who bought ImmunoGen, who sold ImmunoGen (IMGN) stock, and who holds a large position in ImmunoGen.

Fund Name Number of Shares Share Valuation As Of
PRIMECAP Management Company 11.92M $126.22M Sept. 30, 2014
FMR 10.26M $108.66M Sept. 30, 2014
ClearBridge Advisors 9.98M $118.27M June 30, 2014
First Trust Advisors 5.81M $61.55M Sept. 30, 2014
Vanguard 5.18M $54.80M Sept. 30, 2014
BB Biotech AG 3.17M $33.53M Sept. 30, 2014
BlackRock Fund Advisors 2.92M $30.94M Sept. 30, 2014
STATE STREET CORPORATION 2.82M $29.81M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.40M $25.45M Sept. 30, 2014
Sectoral Asset Management 2.27M $24.04M Sept. 30, 2014
OrbiMed Advisors 1.93M $28.14M Sept. 30, 2012
Artal Group S.A. 1.90M $20.12M Sept. 30, 2014
Wellington Management Company 1.31M $15.49M June 30, 2014
Gail Mannix 1.24M $13.09M Sept. 30, 2014
NORTHERN TRUST 1.16M $17.30M March 31, 2014

Who sold ImmunoGen?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.37M $34.81M
Maverick Capital Dec. 31, 2000 1.57M $33.57M